Pages that link to "Q35023530"

The following pages link to Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV. (Q35023530):

Displayed 15 items.

• Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice. (Q30353490) ‎ (← links)
• Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody (Q33205911) ‎ (← links)
• Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters (Q33262275) ‎ (← links)
• Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus (Q33930424) ‎ (← links)
• Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens (Q36017488) ‎ (← links)
• Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets (Q36631937) ‎ (← links)
• Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. (Q37347813) ‎ (← links)
• Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10. (Q37683080) ‎ (← links)
• Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response (Q38707583) ‎ (← links)
• Deliberate removal of T cell help improves virus-neutralizing antibody production. (Q45603036) ‎ (← links)
• Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS-CoV F(ab')(2) in macaque (Q48375720) ‎ (← links)
• The latest evidence for possible HIV-1 curative strategies. (Q52430553) ‎ (← links)
• Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime–boost approach (Q57165945) ‎ (← links)
• Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India (Q57167018) ‎ (← links)
• Requirement for neutralizing antibodies to control bone marrow transplantation-associated persistent viral infection and to reduce immunopathology (Q58657735) ‎ (← links)